Erste Group Upgrades Amgen (AMGN) to Buy
Get Alerts AMGN Hot Sheet
Price: $360.45 -0.81%
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 60
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 60
Join SI Premium – FREE
(Updated - February 5, 2025 1:36 PM EST)
Erste Group analyst Hans Engel upgraded Amgen (NASDAQ: AMGN) from Hold to Buy.
The analyst comments "Amgen has a higher operating margin and a higher return on equity than the sector average. Sales and operating income will continue to rise in the coming quarters. The stock is attractively valued according to the P/E ratio. It also has a comparatively high dividend yield."
For an analyst ratings summary and ratings history on Amgen click here. For more ratings news on Amgen click here.
Shares of Amgen closed at $289.02 yesterday.
You May Also Be Interested In
- Stifel Starts Arrowhead Pharma (ARWR) at Buy
- Stifel on SpaceX (SPCX): 'One amazing stat...'
- Amgen (AMGN) PT Raised to $312 at BofA Securities
Create E-mail Alert Related Categories
Analyst Comments, UpgradesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share